Investors Snag FATE Even Cheaper Than Its Secondary Stock Offering
October 11, 2018 at 15:15 PM EDT
Looking back to 21 days ago, Fate Therapeutics Inc (FATE) priced a 9,259,260 share secondary stock offering at $13.50 per share. Buyers in that offering made a considerable investment into the company, expecting that their investment would go up over the course of time..
